Tag: Phase II Trial

AR101+dupilumab

Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...

Trial Will Build on the Positive, Pivotal Phase 3 PALISADE Trial of AR101.
AR101+dupilumab

Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...

Study scheduled to commence next week.
Lactobacillus rhamnosus

Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate

Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.
Jigsaw Puzzle

Milk and Peanut Clinical Trial Advances

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.
Xolair (omalizumab)

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.
Peanut Therapy

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.
Test Tubes

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Promising OIT Results from UNC Phase II Trial

"The first-ever clinical study of preschoolers allergic to peanuts could lead to safe and effective treatment for millions of people."

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Connect with Us

34,634FansLike
95FollowersFollow
181FollowersFollow
2,299FollowersFollow
5,169FollowersFollow
37SubscribersSubscribe